Lung Cancer Europe is the voice of lung cancer patients, their families and survivors at a European level and it aims to raise awareness for lung cancer.
Lung Cancer Europe is the voice of lung cancer patients, their families and survivors at a European level. LuCE provides a European platform for already existing lung cancer patient advocacy groups and supports the establishment of national lung cancer patient groups in different European countries where such groups do not yet exist.
LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care. LuCE also supports national lung cancer patient groups in helping raise awareness for lung cancer among the European public.
Lung Cancer Europe advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.
11/10/2015 – LuCE EU Position Paper 2015: “With an estimated incidence of over 449 000 cases per year, lung cancer is one of the most common malignancies in Europe."
Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist.
Click here for more information on how LuCE works with sponsors.
Is a professor in the thoracic oncology unit at San Luigi Hospital in Orbassano, Italy, part of the University of Turin. Prof. Novello advocates a multidisciplinary approach towards diagnosis of lung cancer and stresses the need for modernizing lung cancer research. Her research interests include thoracic malignancies, gender differences in lung cancer, experimental studies on sarcoidosis, on basic and clinical applied research on lung cancer, including pharmacogenomics. She is involved in several European clinical trials evaluating new approaches in diagnosis and lung cancer therapy.
Is an associate professor and consultant in thoracic surgery at Copenhagen University Hospital, Rigshospitalet. He is chairman of the surgical subcomittee of the IASLC strategic screening advisory committee. Prof. Peterson advocates for the early detection of patients with lung cancer through CT scans and calls for the EU and its member states to prepare guidelines on screening to ensure adequate follow up and management.
With his international NELSON study, prf. Groen has shown the importance of annual screening to help early detection of lung cancer among (former) smokers. He supports LuCE's calls on the Europe Union to increase the research funding allocated to lung cancer research and to develop guidelines on lung cancer screening and diagnosis.
António M. F. Araújo is the Head of the Service of Medical Oncology at Centro Hospitalar do Porto, and is Assistant Professor at Institute of Biomedical Sciences Abel Salazar – Porto University, since Mars 2014. Member of the Portuguese National Council for Oncology, since 2013, and member of the Advisory Board of the Portuguese Health Regulatory Authority, since February 2015.